Cryo-EM in drug discovery: achievements, limitations and prospects

JP Renaud, A Chari, C Ciferri, W Liu… - Nature reviews Drug …, 2018 - nature.com
Cryo-electron microscopy (cryo-EM) of non-crystalline single particles is a biophysical
technique that can be used to determine the structure of biological macromolecules and …

Organic carbamates in drug design and medicinal chemistry

AK Ghosh, M Brindisi - Journal of medicinal chemistry, 2015 - ACS Publications
The carbamate group is a key structural motif in many approved drugs and prodrugs. There
is an increasing use of carbamates in medicinal chemistry and many derivatives are …

Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS

AK Ghosh, HL Osswald, G Prato - Journal of medicinal chemistry, 2016 - ACS Publications
HIV-1 protease inhibitors continue to play an important role in the treatment of HIV/AIDS,
transforming this deadly ailment into a more manageable chronic infection. Over the years …

The structural biology of HIV-1: mechanistic and therapeutic insights

A Engelman, P Cherepanov - Nature Reviews Microbiology, 2012 - nature.com
Three-dimensional molecular structures can provide detailed information on biological
mechanisms and, for cases in which the molecular function affects human health, can …

Boron containing compounds as protease inhibitors

R Smoum, A Rubinstein, VM Dembitsky… - Chemical …, 2012 - ACS Publications
Proteases form one of the largest and more important groups of enzymes. They selectively
catalyze the hydrolysis of peptide bonds and can be divided into four major classes …

Structure-based strategies for drug design and discovery

ID Kuntz - Science, 1992 - science.org
Most drugs have been discovered in random screens or by exploiting information about
macromolecular receptors. One source of this information is in the structures of critical …

Inhibitors of HIV-1 protease: a major success of structure-assisted drug design

A Wlodawer, J Vondrasek - Annual review of biophysics and …, 1998 - annualreviews.org
▪ Abstract Retroviral protease (PR) from the human immunodeficiency virus type 1 (HIV-1)
was identified over a decade ago as a potential target for structure-based drug design. This …

HIV-1 protease: mechanism and drug discovery

A Brik, CH Wong - Organic & biomolecular chemistry, 2003 - pubs.rsc.org
It has now been two decades since acquired immunodeficiency syndrome (AIDS) was first
reported by the US Center for Diseases Control (CDC). A few years later, it was found that a …

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

PYS Lam, PK Jadhav, CJ Eyermann, CN Hodge, Y Ru… - Science, 1994 - science.org
Mechanistic information and structure-based design methods have been used to design a
series of nonpeptide cyclic ureas that are potent inhibitors of human immunodeficiency virus …

Proline-dependent structural and biological properties of peptides and proteins

A Yaron, F Naider, S Scharpe - Critical reviews in biochemistry and …, 1993 - Taylor & Francis
Proline residues confer unique structural constraints on peptide chains and markedly
influence the susceptibility of proximal peptide bonds to protease activity. This review …